Apex Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-40,903	Closed	-$1.1M	–	240
2013 Q2	$1.1M	Buy	+40,903	New	+$1.1M	0.05%	159